


The Fund aims to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| Total | 4.7% |
| Telefonica | 3.9% |
| NESTLE SA COMSTK | 3.3% |
| Roche Hldgs (genus) | 3.1% |
| Novartis (regd) | 2.8% |
| Sanofi-aventis | 2.5% |
| Anheuser-busch Inbev | 2.2% |
| Siemens Ag | 2.2% |
| Vivendi | 1.9% |
| Carrefour | 1.9% |
| Key | % Net Assets |
|---|---|
| 4.7% | |
| 3.9% | |
| 3.3% | |
| 3.1% | |
| 85% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 30/09/2002 |
|---|---|
| Fund Manager | Richard Wiseman |
| TER | 1.60 (31-Oct-2008) |
| Minimum Investment | |
|---|---|
| Initial | 2000 |
| Additional | 1,000 |
| Savings | 100 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research